Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | UNG | P13051 | 7/20 | 1.00 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | XBP1 | P17861 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.45 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.43 |
| ▸ | SPHK1 | Q9NYA1 | 5/20 | 0.41 |
| ▸ | SPHK2 | Q9NRA0 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7961022 | 1.00 | UNG (1.00) | UNGTP53MAPTHPGDXBP1 | |
| SCHEMBL7960794 | 0.94 | UNG (1.00) | UNGTP53MAPTHPGDXBP1 | |
| SCHEMBL7960912 | 0.92 | UNG (0.85) | UNGTP53MAPTHPGDXBP1 | |
| SCHEMBL7962206 | 0.89 | UNG (0.79) | UNGTP53MAPTHPGDXBP1 | |
| SCHEMBL7961025 | 0.87 | UNG (1.00) | UNGTP53MAPTHPGDXBP1 | |
| SCHEMBL7962511 | 0.87 | UNG (1.00) | UNGTP53MAPTHPGDXBP1 | |
| SCHEMBL7951393 | 0.86 | UNG (0.90) | UNGTP53MAPTHPGDXBP1 | |
| SCHEMBL7951048 | 0.86 | UNG (0.75) | UNGTP53MAPTHPGDXBP1 | |
| SCHEMBL7961004 | 0.83 | UNG (0.72) | UNGTP53MAPTHPGDXBP1 | |
| SCHEMBL7964267 | 0.83 | UNG (0.72) | UNGTP53MAPTHPGDXBP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6177437-B1 | VIRICIDES | UNIVERSITY OF MASSACHUSETTS MEDICAL CENTER | 2001-01-23 | — | — | US | claimed |
| US-20230002746-A1 | BASE-EDITING SYSTEMS | INARI AGRICULTURE TECHNOLOGY, INC. (US) | 2023-01-05 | — | — | US | disclosed |
| US-6177437-B1 | VIRICIDES | UNIVERSITY OF MASSACHUSETTS MEDICAL CENTER | 2001-01-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230002746-A1 | BASE-EDITING SYSTEMS | UNG, DCTD, CDA | UNG 1/4885TP53 1192/4885MAPT 4152/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.